Form 4: Walgreens Boots Alliance Director Acquires Phantom Stock Units as Compensation

Robert Luther Huffines, a director at Walgreens Boots Alliance, acquired phantom stock units as part of non-employee director compensation.

Summary

• On April 25, 2024, Robert Luther Huffines, a director of Walgreens Boots Alliance, Inc., acquired 1,420.45 phantom stock units.
• These units were issued as non-employee director compensation under the company's 2021 Omnibus Incentive Plan.
• Each phantom stock unit is economically equivalent to one share of Walgreens Boots Alliance common stock.
• The price of the derivative security is $17.6.
• These units will be settled following the termination of service as a director, according to the plan's terms.
• Following the transaction, Huffines beneficially owns 1,853.44 derivative securities, which includes phantom stock units issued in lieu of dividends through April 15, 2024.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally. The use of phantom stock units suggests a commitment to aligning director interests with shareholder value, contributing to a slightly positive sentiment.

Positives

• The acquisition of phantom stock units aligns the director's interests with the company's performance.
• The compensation structure is part of a pre-existing plan, suggesting transparency and governance.
• The director now holds 1,853.44 derivative securities.

Future Outlook

The phantom stock units will be settled following termination of service as a director in accordance with the terms and conditions of the Plan.

Industry Context

Director compensation in the form of stock and stock options is a common practice in publicly traded companies to align the interests of directors with those of shareholders. The use of phantom stock units is a variation of this practice.

Comparison to Industry Standards

• Director compensation packages vary widely across industries and company sizes.
• Companies like CVS Health and Rite Aid also utilize equity-based compensation for their directors.
• The specific amount and type of equity compensation are typically benchmarked against peer companies to ensure competitiveness and alignment with shareholder interests.

Stakeholder Impact

• Shareholders may view the equity-based compensation positively as it aligns director interests with company performance.
• The compensation structure could influence director decision-making to focus on long-term value creation.

Key Dates